Sage Journals: Discover world-class research

Open access

Research article

First published 2026-1

Managing reactivation of multiple sclerosis during treatment with natalizumab

Nathaniel Lizak, Sifat Sharmin, Dana Horáková [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2019-8

Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis

Eva Rosa Petersen, Helle Bach Søndergaard, Julie Hejgaard Laursen [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2014-9

Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis

Sandra Amor, Baukje J van der Star, Isabel Bosca [...]

Multiple Sclerosis Journal

Free access

Review article

First published 2009-03

Review: Natalizumab in the treatment of multiple sclerosis

Özgür Yaldizli, Norman Putzki

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2011-8

Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment

Kerstin Hellwig, Aiden Haghikia, Ralf Gold

Multiple Sclerosis Journal

Retricted access

Research article

First published 2012-11

Severe haematological complications during treatment with natalizumab

L Midaglia, M Rodriguez Ruiz, D Muñoz-García

Multiple Sclerosis Journal

Open access

Review article

First published 2017-9

The role of natalizumab in the treatment of multiple sclerosis: benefits and risks

Barry A. Singer

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2005-11

Natalizumab for the Treatment of Multiple Sclerosis and Crohn's Disease

Kendra A Keeley, Michael P Rivey, Douglas R Allington

Annals of Pharmacotherapy

Free access

Research article

First published 2014-1

Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy

Robert Hoepner, Stefanie Dahlhaus, Susanne Kollar [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2024

Real-world evidence and patient preference for subcutaneous versus intravenous natalizumab in the treatment of relapsing-remitting multiple sclerosis – initial results from the observational SISTER study

Ralf Gold, Stephan Schmidt, Florian Deisenhammer [...]

Therapeutic Advances in Neurological Disorders

Search results